Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance

Obesity Research

Volumn 13, Issue 3, 2005, Pages 501-506

  Zacharova, Jelena ^a,b   Chiasson, Jean Louis ^a,c   Laakso, Markku ^a,b  

^a STOP NIDDM Study Group   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Insulin; Leptin re ceptor; Pentanucleotide insertion polymorphism of the 3 untranslated region; STOP Noninsulin Dependent Diabetes Mellitus trial; Type 2 diabetes

Indexed keywords

CELL SURFACE RECEPTOR; DNA; LEPTIN RECEPTOR; PLACEBO;

ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC VARIABILITY; GENETICS; GENOTYPE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEXUAL DEVELOPMENT; WEIGHT REDUCTION;

ADULT; AGED; ALLELES; ANTHROPOMETRY; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DNA; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PLACEBOS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CELL SURFACE; SEX CHARACTERISTICS; VARIATION (GENETICS); WEIGHT LOSS;

EID: 22844440105     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.52     Document Type: Article

References (20)

1. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763-70.
2. Chung WK, Power-Kehoe L, Chua M, et al. Exonic and intronic sequence variation in the human leptin receptor gene (LEPR). Diabetes. 1997;46:1509-11.
3. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387:903-8.
4. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392:398-401.
5. Wauters M, Mertens I, Rankinen T, et al. Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance. J Clin Endocrinol Metab. 2001;86:3227-32.
6. Ge H, Huang L, Pourbahrami T, Li C. Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. J Biol Chem. 2002;277:45898-903.
7. Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 2002;415:339-43.
8. Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes. 1997;46:313-6.
9. Seufert J, Kieffer TJ, Leech CA, et al. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab. 1999;84:670-6.
10. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-5.
11. Thompson DB, Janssen RC, Ossowski VM, Prochazka M, Knowler WC, Bogardus C. Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians. Diabetes. 1995;44:478-81.
12. Francke S, Clement K, Dina C, et al. Genetic studies of the leptin receptor gene in morbidly obese French Caucasian families. Hum Genet. 1997;100:491-6.
13. Lakka HM, Oksanen L, Tuomainen TP, Kontula K, Salonen JT. The common pentanucleotide polymorphism of the 3′-untranslated region of the leptin receptor gene is associated with serum insulin levels and the risk of type 2 diabetes in non-diabetic men: a prospective case-control study. J Intern Med. 2000;248:77-83.
14. Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care. 1998;21:1720-5.
15. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM trial. Lancet. 2002;359:2072-7.
16. Takaya K, Ogawa Y, Hiraoka J, et al. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet. 1996;14:130-1.
17. Gotoda T, Manning BS, Goldstone AP, et al. Leptin receptor gene variation and obesity: lack of association in a white British male population. Hum Mol Genet. 1997;6:869-76.
18. Thompson DB, Ravussin E, Bennett PH, Bogardus C. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet. 1997;6:675-9.
19. Oksanen L, Kaprio J, Mustajoki P, Kontula K. A common pentanucleotide polymorphism of the 3′-untranslated part of the leptin receptor gene generates a putative stem-loop motif in the mRNA and is associated with serum insulin levels in obese individuals. Int J Obes Relat Metab Disord. 1998;22:634-40.
20. Chiasson JL, Josse RG, Leiter LA, et al. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. Diabetes Care. 1996;19:1190-3.